Patient-Funded Trials: Opportunity or Liability?

Area of Science:

• Clinical Research
• Translational Science
• Health Policy

Background:

• Patient-funded trials (PFTs) are increasingly utilized to expedite clinical translation of research findings.
• However, PFTs often bypass established review processes that ensure scientific rigor, relevance, efficiency, and fairness.
• This gap can potentially compromise the integrity and impact of patient-driven research.

Purpose of the Study:

• To highlight the challenges associated with patient-funded trials (PFTs) regarding scientific standards.
• To propose the implementation of merit review systems for PFTs.
• To offer foundational criteria for evaluating PFT protocols.

Main Methods:

• Review of current practices and challenges in patient-funded trials (PFTs).
• Development of recommendations for funding bodies and research institutions.
• Formulation of basic criteria for assessing PFT protocols.

Main Results:

• Patient-funded trials (PFTs) present a unique pathway for clinical translation but lack inherent quality control mechanisms.
• The absence of rigorous review can impact the reliability and ethical conduct of PFTs.
• Standardized evaluation criteria are needed to ensure the scientific merit of PFTs.

Conclusions:

• Funding bodies and research institutions should establish merit review processes for patient-funded trials (PFTs).
• Implementing clear evaluation criteria will enhance the rigor, relevance, efficiency, and fairness of PFTs.
• Such measures are crucial for maintaining the integrity of clinical translation driven by patient funding.